You just read:

AcelRx Pharmaceuticals Presentation at JAB Burn Symposium Highlights Potential of DSUVIA™ for Use in Burn Victims with Moderate-to-Severe Acute Pain

News provided by

AcelRx Pharmaceuticals, Inc.

13 Feb, 2017, 07:00 ET